Karuna Therapeutics to Present at Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will present at the following upcoming investor conferences:

William Blair 42^nd Annual Growth Stock Conference
Date: Wednesday, June 8, 2022
Time: 5:00 p.m. ET

Goldman Sachs 43^rd Annual Global Healthcare Conference
Date: Tuesday, June 14, 2022
Time: 5:00 p.m. ET

A live webcast of the presentations will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna’s website following the conference.

About Karuna Therapeutics

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005094/en/

Investor:

Alexis Smith

518-338-8990

asmith@karunatx.com



Media:

Lauren Sneider

917-886-0247

lsneider@karunatx.com

Source: Karuna Therapeutics, Inc.